Lion Point Capital, LP’s Praxis Precision Medicines I Position
Does Lion Point Capital, LP own Praxis Precision Medicines I (PRAX)? Yes — 4.5K shares worth $1M (+8.57% of its 13F portfolio) as of Q1 2026.
Position Value
$1M
Q1 2026
Shares
4.5K
% of Portfolio
+8.57%
Quarters Held
3
currently held
Position History PRAX
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lion Point Capital, LP’s full portfolio or all institutional holders of PRAX.